Safety and Efficacy of PRO 542 in the Treatment of HIV-Infected Patients
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine any adverse effects of PRO 542 after administration
and to determine the anti-HIV effects of PRO 542 in the patient.